SOMAVERT 25 mg, powder and solvent for solution for injection 30 bottles
Active ingredients: Pegvisomant
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injection30 bottlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOMAVERT 25 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 30 flacon(s) en verre - 30 seringue(s) préremplie(s) en verre
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62331391CIP73002386CIP133400930023860Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGVISOMANTpoudre | 25 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.